Every earnings call for GEMAROMA — management tone, guidance, KPIs and promise tracking, quarter by quarter.
GEMAROMA · 3 transcripts · Chemicals · latest Q4 FY26Gem Aromatics Limited has 3 earnings calls on record here, a Chemicals company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Revenue (Standalone) ₹112 cr; EBITDA (Consolidated) ₹16 cr; EBITDA Margin (Consolidated) 14.2%. Consolidated revenue grew 40% QoQ to INR 110 crores.
Read full transcript & analysisConsolidated Revenue ₹79 cr; Consolidated EBITDA ₹7 cr; Consolidated EBITDA Margin 8.9%. Consolidated revenue from operations stood at INR 78.9 crores in Q3 FY26.
Read full transcript & analysisRevenue (Q2 FY26) ₹90 cr; EBITDA (Q2 FY26) ₹3 cr; EBITDA Margin (Q2 FY26) 3.4%. Successful IPO listing on NSE and BSE on August 26, 2025.
Read full transcript & analysis